AbbVie Corporation reported 4 lobbying communications with federal officials between Jul 2, 2026 and Jul 23, 2026.
Officials contacted: Bradley Bennett (Pharmacist Consultant); Cory Olishansky (Consul and Trade Commissioner); Dylan Radke (Pharmacist Consultant); Julien Rosan (Life Sciences Trade Commissioner); Karen Fortin (Executive Director); Madeleine Fequiere (Consul General of Canada in Chicago).
On the agenda: Communications regarding the value assessment of new medicines by Canada's Drug Agency (CDA) and the design of proposed new work streams, insofar as the federal government is a funder and holds a seat on the Board of Directors; The pan Canadian Pharmaceutical Alliance (pCPA) with respect to public formulary listing of new medicines, insofar as the federal government is a participating jurisdiction and holds a seat on the Board of Directors; Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape.
